Dany et al. analyzed CerS1 mRNA and its impact on survival using the AML database in the Cancer Genome Atlas Research Network, and found that 10 out of 166 AML patients exhibited upregulated CerS1 mRNA expression, and showed significantly longer overall and disease-free survival compared with those with basal CerS1 mRNA abundance [20]. The gene discussed is CERS1; the disease is acute myeloid leukemia.